Immuron (IMRN) Return on Capital Employed (2018 - 2024)

Immuron (IMRN) recorded quarterly Return on Capital Employed of 56732272386237.33% in Q4 2024, up 30885015529.52% quarter-over-quarter from 183688.66% in Q4 2023, and up 5673227256992599.0% on a YoY basis from N/an in Q1 2024.

Immuron (IMRN) Return on Capital Employed (2018 - 2024) Analysis & Trends

Immuron's Return on Capital Employed history runs 7 years deep, the most recent figure standing at 56732272386237.33% for Q4 2024.

  • In Q4 2024, Return on Capital Employed rose 5673227256992599.0% year-over-year to 56732272386237.33%; the TTM figure through Dec 2024 stood at 56732272386237.33% (up 5673227256992599.0% YoY), while the FY2025 annual figure was 166.05%, down 13738.0% from the prior year.
  • Return on Capital Employed was 56732272386237.33% for Q4 2024 at Immuron, up from 183688.66% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 56732272386237.33% in Q4 2024 to a low of 183688.66% in Q4 2023.
  • Historically, Return on Capital Employed has averaged 9455378647625.91% across 5 years, with a median of 89613.68% in 2023.
  • The sharpest annual moves came in 2021 and 2024: Return on Capital Employed slumped 13758298 bps in 2021, then surged 2000000000 bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 8.56% in 2020, then plunged by 1606597 bps to 137574.42% in 2021, then soared by 39 bps to 84234.89% in 2022, then plunged by 118 bps to 183688.66% in 2023, then soared by 2000000000 bps to 56732272386237.33% in 2024.
  • The last three Return on Capital Employed figures came in at 56732272386237.33% (Q4 2024), 183688.66% (Q4 2023), and 94992.46% (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 450.31%
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 51.73%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -107.40%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 21.10%
9 Abivax 91.96 Bn 91.96 Bn - -50.43%
10 Immuron 921.61 Mn 921.58 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 56,732,272,386,237.33%
Dec 31, 2023 -183,688.66%
Jun 30, 2023 -94,992.46%
Dec 31, 2022 -84,234.89%
Dec 31, 2021 -137,574.42%
Dec 31, 2020 8.56%
Dec 31, 2019 158.52%
Dec 31, 2018 49.53%